These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9542692)
1. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction. Lewis RW Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692 [No Abstract] [Full Text] [Related]
2. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction. Porst H Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415 [TBL] [Abstract][Full Text] [Related]
3. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. Engel JD; McVary KT Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580 [TBL] [Abstract][Full Text] [Related]
4. [Transurethral alprostadil administration with MUSE ("Medicated Urethral System for Erection"). Current overview and personal experiences]. Porst H Urologe A; 1998 Jul; 37(4):410-6. PubMed ID: 9738294 [TBL] [Abstract][Full Text] [Related]
5. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)]. Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074 [TBL] [Abstract][Full Text] [Related]
7. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea. Kim SC; Ahn TY; Choi HK; Choi NG; Chung TG; Chung WS; Hwang TK; Hyun JS; Jung GW; Kim CI; Kim JJ; Kim SW; Lee CH; Lee KS; Lee WH; Min KS; Moon KH; Paic JS; Park KS; Park NC; Park YK; Seo JK; Seo KK; Shin JS; Yoon YR; Lee WC Int J Impot Res; 2000 Apr; 12(2):97-101. PubMed ID: 11052635 [TBL] [Abstract][Full Text] [Related]
8. Use of transurethral alprostadil (MUSE) (prostaglandin E1) for glans tumescence in a patient with penile prosthesis. Chew KK; Stuckey BG Int J Impot Res; 2000 Jun; 12(3):195-6. PubMed ID: 11045915 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection. Guay AT; Perez JB; Velásquez E; Newton RA; Jacobson JP Eur Urol; 2000 Dec; 38(6):671-6. PubMed ID: 11111182 [TBL] [Abstract][Full Text] [Related]
10. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction]. Amar E Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573 [TBL] [Abstract][Full Text] [Related]
11. Titration study of MUSE (Medicated Urethral System for Erection) in erectile dysfunction. Chiang HS; Wen TC; Liang JF J Formos Med Assoc; 2000 Dec; 99(12):926-30. PubMed ID: 11155746 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians. Pangkahila WI Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984 [TBL] [Abstract][Full Text] [Related]
13. Thalassaemic men affected by erectile dysfunction treated with transurethral alprostadil: case report. Lombardo T; Giammusso B; Frontini V; D'Arpa S; Pafumi C; Caruso S Hum Reprod; 2000 Nov; 15(11):2375-8. PubMed ID: 11056136 [TBL] [Abstract][Full Text] [Related]
14. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933 [TBL] [Abstract][Full Text] [Related]
15. Transurethral alprostadil for the treatment of erectile dysfunction: results of a multicentre trial. Li MK; Lim PH; Wong MY; Fok A; Chia SJ; Consigliere D; Adaikan PG; Moorthy P Ann Acad Med Singap; 2000 Nov; 29(6):727-31. PubMed ID: 11269978 [TBL] [Abstract][Full Text] [Related]
16. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study. Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I Urology; 2000 Jan; 55(1):109-13. PubMed ID: 10654905 [TBL] [Abstract][Full Text] [Related]
18. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. Raina R; Pahlajani G; Agarwal A; Zippe CD BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346 [TBL] [Abstract][Full Text] [Related]
20. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Bodner DR; Haas CA; Krueger B; Seftel AD Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]